Antibody drugs such as monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies garnered increased interest in research and development circles. Sino ...
Hosted on MSN
Why Is Drug Discovery So Difficult?
The vast majority of drug development programs fail during clinical testing. Focusing on flaws in preclinical models and trial design, this article offers practical improvements through predictive ...
The U.S. Food and Drug Administration (FDA) issued its third Patient-Focused Drug Development (PFDD) guidance titled, “Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback